Oragenics Inc (OGEN): Operating Cash Flow
-$9.25M
Year ended 2025-12-31
-$10.21M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$9.25M | n/m | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | -$8.60M | n/m | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | -$7.29M | n/m | 2025-03-14, From 2023-01-01 |
| 2022-12-31 | -$15.23M | n/m | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | -$13.47M | n/m | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | -$16.95M | n/m | 2022-07-29, From 2020-01-01 |
| 2019-12-31 | -$13.01M | n/m | 2021-03-01, From 2019-01-01 |
| 2018-12-31 | -$9.08M | n/m | 2020-03-04, From 2018-01-01 |
| 2017-12-31 | -$6.36M | n/m | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | -$7.08M | n/m | 2018-02-16, From 2016-01-01 |
| 2015-12-31 | -$5.19M | n/a | 2017-02-27, From 2015-01-01 |
| No annual figure between 2012-12-31 and 2015-12-31. | |||
| 2012-12-31 | -$5.21M | n/m | 2013-03-26, From 2012-01-01 |
| 2011-12-31 | -$5.49M | n/m | 2013-03-26, From 2011-01-01 |
| 2010-12-31 | -$6.45M | n/a | 2012-04-16, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Oragenics Inc (OGEN) | 2025-12-31 | -$9.25M | n/m |
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | -$22.78M | n/m |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | -$3.31M | n/m |
| Genprex, Inc. (GNPX) | 2025-12-31 | -$15.31M | n/m |
| Longeveron Inc. (LGVN) | 2025-12-31 | -$18.64M | n/m |
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | -$8.19M | n/m |
| MAIA Biotechnology, Inc. (MAIA) | 2025-12-31 | -$18.84M | n/m |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | -$9.48M | n/m |
| FibroBiologics, Inc. (FBLG) | 2025-12-31 | -$16.39M | n/m |
Compare OGEN, MDCX, KRSA, GNPX side by side · Screen every company in Pharmaceutical Preparations ↗